Clinical Trials
2 trialsNCT02098967 2018-05-17
A Study of the Safety and Pharmacokinetics of RO6839921, An MDM2 Antagonist, in Patients With Advanced Cancers, Including Acute Myeloid Leukemia.
Hoffmann-La Roche
Phase 1 Completed
NCT01677780 2017-07-07
An Extension Study of RO5045337 in Participants Participating in Previous Roche-sponsored Cancer Studies
Hoffmann-La Roche
Phase 1 Completed